Whitepaper & Video Center

Pharma leaders joined us live on November 25th 2025 for an engaging and interactive webinar with Massimo Crudeli, Director of Client Solutions at STAEDEAN. Data integrity in pharma supply chains is more than a compliance requirement - it’s the foundation of trust, efficiency, and resilience. Yet, many pharma leaders continue to face challenges. This webinar will address these critical challenges head-on, watch it now!

The 2025 LogiPharma AI & Tech Report reveals how pharmaceutical supply chains are moving from AI pilots to practical deployment. With rising pressure from regulation, patient demand, and global disruption, leaders are using AI to strengthen resilience, improve compliance, and anticipate risk. To build this picture, WBR Insights surveyed 100 senior supply chain leaders in Q2 2025, including Directors of Supply Chain, Global Heads of Logistics, and senior planners.

The explosive growth of AI data centres is transforming global supply chains - but also straining them like never before. To keep pace, leaders are turning to Machine Learning generative AI, and a new generation of intelligent agents that deliver agility, cognition, and autonomy at scale. In this session, we’ll explore how AI agents can unlock competitive advantage for high-tech supply chains. Watch it now!

To gauge how prepared pharmaceutical companies were for the impact of the potential tariff changes, STAEDEAN conducted a targeted industry survey earlier this year. A total of 130 pharma professionals across the U.S. and Europe responded, representing organizations of all sizes. The lesson? Cost efficiency alone is no longer enough. Agility, visibility, and resilience have become essential.

This year’s LogiPharma event in Lyon wasn’t just a reflection of how far we’ve come—it was a powerful showcase of where the pharmaceutical supply chain is headed. The Post Event Report is packed with key insights, trends, and expert perspectives from this year’s landmark event, including our live session polling results and exclusive attendee interviews!

Despite the surging interest in AI within the life sciences supply chain, the industry lacks a clear understanding of AI’s current capabilities and its potential to drive efficiency. This knowledge gap hinders the development of tangible solutions. As a result, WBR Insights surveyed 100 supply chain leaders from various organisations in Q2 of 2024 to unpack the top challenges when integrating AI and innovative solutions to unlock the full potential of new technology.